A pediatric rodent model for chronic cisplatin-related cognitive impairment is proposed. Extent of cognitive impairment in the chemotherapy exposed pediatric rodent population appears to vary based on age of exposure and neurodevelopmental stage. Rats exposed to cisplatin during infancy show hippocampal-dependent cognitive impairment. Rats exposed to cisplatin during adolescence show more global cognitive deficits.